|
Product bid upon
|
Intercept
|
0.97
|
−1.60
|
−1.20
|
|
(0.71)+
|
(0.72)
|
(0.72)
|
|
Nicorette
|
0.89***
|
0.89***
|
0.89***
|
|
(0.13)
|
(0.13)
|
(0.13)
|
|
Ariva
|
0.35***
|
0.35***
|
0.37***
|
|
(0.13)
|
(0.13)
|
(0.13)
|
|
In treatment where offered, but rejected opportunity to take a trial, relative to control group
|
Offered but rejected Snus
|
−0.54
|
−0.06
|
−0.13
|
|
(0.39)
|
(0.35)
|
(0.35)
|
|
Offered but rejected Nicorette
|
0.95**
|
0.87**
|
0.50
|
|
(0.46)
|
(0.41)
|
(0.40)
|
|
Offered but rejected Ariva
|
−0.08
|
0.05
|
0.01
|
|
(0.46)
|
(0.41)
|
(0.40)
|
|
In treatment where offered, and accepted opportunity to take a trial, relative to control group
|
Tried Snus
|
−0.07
|
0.11
|
0.08
|
|
(0.42)
|
(0.38)
|
(0.37)
|
|
Tried Nicorette
|
0.20
|
0.27
|
0.23
|
|
(0.38)
|
(0.34)
|
(0.33)
|
|
Tried Ariva
|
0.18
|
−0.04
|
−0.06
|
|
(0.38)
|
(0.34)
|
(0.33)
|
|
Age
|
−0.00
|
0.01
|
0.00
| |
|
(0.01)
|
(0.01)
|
(0.01)
| |
|
Income
|
−0.09
|
−0.08
|
−0.06
| |
|
(0.10)
|
(0.09)
|
(0.09)
| |
|
Education
|
0.12
|
−0.08
|
0.15
| |
|
(0.11)
|
(0.09)
|
(0.10)
| |
|
Female
|
0.15
|
0.14
|
0.11
| |
|
(0.28)
|
(0.25)
|
(0.24)
| |
|
Race/Ethnicity
|
Black vs. white
|
0.16
|
0.03
|
−0.01
|
|
(0.32)
|
(0.28)
|
(0.29)
|
|
Other vs. white
|
0.57
|
0.05
|
0.13
|
|
(0.48)
|
(0.43)
|
(0.42)
|
|
State
|
South Carolina (vs. New York)
|
−0.82
|
0.09
|
0.03
|
|
(0.31)
|
(0.29)
|
(0.30)
|
|
Pennsylvania (vs. New York)
|
−1.04***
|
−0.87***
|
−0.84***
|
|
(0.32)
|
(0.29)
|
(0.28)
|
|
Ever used smokeless tobacco
|
0.10
|
0.09
|
0.04
|
|
(0.29)
|
(0.26)
|
(0.25)
|
|
Worried about their quality of life because of smoking
|
−0.01
|
0.06
|
−0.01
|
|
(0.24)
|
(0.22)
|
(0.21)
|
|
Estimate of the cost of smokeless tobacco products
|
0.02**
|
0.02***
|
0.02***
|
|
(0.01)
|
(0.01)
|
(0.01)
|
|
Bid for cigarettes
| |
0.40***
|
0.38***
|
| |
(0.05)
|
(0.05)
|
|
Participant preferred menthol cigarettes
| | |
−0.06
|
| |
(0.23)
|
